News about Global Pharma

Alkermes Announces Agreement to Sell Athlone, Ireland Facility to Novo Nordisk

Under the terms of the agreement, upon the closing of the transaction, Alkermes will be entitled to a one-time cash payment of $92.5 million for the facility and related assets, subject to customary adjustments in accordance with the agreement.

Global Pharma | 15/12/2023 | By Manvi |  882

Teda Smart Pharma, Asrega Ink MoU to Tap Malaysia's Growing Vending Machine Market

Malaysia's vending machine market has been steadily expanding in recent years due to shifting consumer tastes and rising demand for easy-to-shop options.

Global Pharma | 15/12/2023 | By Manvi |  762

Aptamer Group Signs Material Agreement with Genetic Medicines Company

Under the terms of the agreement, Aptamer Group will use its proprietary platform to discover Optimer binders to enable the specific targeting of genetic medicines to specific cell types.

Global Pharma | 15/12/2023 | By Manvi |  401

Romaco Kilian Tableting Workshop Jointly with BASF

The aim of the event was to develop a pediatric formulation, from prototype to production scale. Live demonstrations from the Kilian laboratory in Cologne were complemented by scientific presentations on the subject of formulation and tableting.

Global Pharma | 15/12/2023 | By Manvi |  305

Lek Pharma Starts USD 400 Million Biologics Facility Construction in Slovenia

The ambitious initiative was set into motion after Sandoz, the parent company of Lek Pharmaceuticals and a global leader in generic and biosimilar medicines, unveiled plans for this state-of-the-art production center in March 2023.

Global Pharma | 14/12/2023 | By Manvi |  2440

BioNTX Announces 10th Annual iC Summit and Support of International Pharma Logistics Masterclass

BioNTX to support DFW Airport's announcement of the upcoming 2024 edition of the Pharma Logistics Masterclass at Pegasus Park.

Global Pharma | 14/12/2023 | By Manvi |  677

Sun Pharma's Specialty Product Ilumetri Included in China's National Reimbursement Drug List

Ilumetri is indicated for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy.

Global Pharma | 14/12/2023 | By Manvi |  1086

Granules India Limited Received ANDA Approval for Pantoprazole Sodium Delayed-Release Tablets

It is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), Protonix Delayed-Release Tablets, 20 mg and 40 mg, of Wyeth Pharmaceuticals LLC.

Global Pharma | 14/12/2023 | By Manvi |  866

Zydus and Daewoong Pharmaceutical Announce Licensing Agreement for Leuprolide Long-Acting Injectable in US

Zydus Lifesciences and Daewoong Pharmaceutical Co., Ltd. announced that they have entered into an exclusive licensing agreement to co-develop and commercialize Leuprolide Acetate for Depot Suspension in six dosage strengths for the United States (US) market.

Global Pharma | 13/12/2023 | By Manvi |  684

ANTABIO Raises Euro 25 Million in Series B Financing

Antabio SAS announced that it has raised Euro 25 million in a series B financing round with subscriptions from the AMR Action Fund.

Global Pharma | 13/12/2023 | By Manvi |  708